ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0777

Rheumatoid Factor B Cell Clones Proliferate Predominantly as Atypical Memory B Cells in Reactive Cervical Lymph Node Follicles Compared to Extrafollicular Sites in Affected Salivary Glands of SjS Patients

Theodoros Ioannis Papadimitriou1, Jing Jing Wang2, Xuehui He3, Sidney van der Zade4, Massis Krekorian5, Prashant Singh6, Erik Dik5, Ger Pruijn5, Tom Gordon2, Hans Koenen7, Martijn Huijnen8 and Rogier Thurlings1, 1Radboudumc, Department of Rheumatology, Nijmegen, Gelderland, Netherlands, 2Flinders University, Adeleide, Australia, 3Radboudumc, Nijmegen, Netherlands, 4Radboudumc, Amsterdam, Netherlands, 5Radboudumc, Nijmegen, Gelderland, Netherlands, 6Radboudumc, Department of Medical BioSciences, Nijmegen, Netherlands, 7Radboudumc, Department of Medical Immunology, Nijmegen, Gelderland, Netherlands, 8Radboudumc, Department of Medical BioSciences, Nijmegen, Gelderland, Netherlands

Meeting: ACR Convergence 2024

Keywords: autoimmune diseases, B-Cell Targets, Cryogloblulinemic Vasculitis, Rheumatoid Factor, Sjögren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Abstracts: B Cell Biology & Targets in Autoimmune & Inflammatory Disease I

Session Type: Abstract Session

Session Time: 1:00PM-2:30PM

Background/Purpose: Sjögren’s syndrome (SjS) is a chronic inflammatory disorder, characterized by formation of autoantibodies. Over time rheumatoid factor (RF) clones can give rise to cryoglobulinemic vasculitis and extranodal marginal zone lymphoma. The latter typically presents in the salivary glands. It is generally speculated that this results from ectopic proliferation of RF clones in the salivary glands. 

Methods: We performed 18F-fluorolevothymidine PET-scans to identify proliferating cells in affected salivary glands and reactive cervical lymph nodes in patients with severe SjS. All included patients (n=16) satisfied the ACR classification criteria. Ultrasound guided biopsies were performed based on PET-avidity. To comparatively characterize SjS autoreactive B cell responses we combined mass-spectrometry antibody sequencing of RF, anti-Ro60, anti-Ro52 and anti-La with multi-omic single-cell analysis (RNAseq, BCRseq, CITEseq) of sorted B cells.

Results: Reactive cervical lymph nodes were enriched for FCRL5+ and interferon-response gene expressing B cells. RF clones proliferated as large IgM+ ZEB+ atypical memory B cell clones in lymph node follicles. There they co-expressed FCRL5, FGR and HCK, enhancers of B cell receptor-mediated activation to immune complexes. SjS LN FCRL5+ memory B cells were transcriptionally similar to a FCRL5+ population in tonsils of patients with chronic tonsilitis. In inflamed salivary glands, RF B cells infiltrated as very large, highly intra-clonally diversified memory B cell clones and clonally related plasma cells. There, only a small fraction of RF clones proliferated at a low level, expressing markers of dysfunction.

Anti-Ro60, anti-Ro52 and anti-La clones proliferated as small IgG1+ CXCR5- memory B cells clones in lymph nodes. In salivary glands, these clones did not proliferate. Instead, they infiltrated as a large number of small plasma cell clones that co-localized with ductal epithelial cells.

After follow-up a number of patients developed clinically overt cryoglobulinemic vasculitis and lymphoma. Rheumatoid factor clones were identified in cryoglobulins that dominated in previous biopsies.

Conclusion: RF clones predominantly proliferate in reactive cervical lymph nodes compared to affected salivary glands of SjS patients. In lymph nodes RF occur as atypical FCLR5+ memory B cell clones, which give rise to highly intra-clonally diversified memory B cell clones that dominate affected salivary glands. These precede cryoglobulinemic vasculitis and lymphomagenesis.


Disclosures: T. Papadimitriou: None; J. Wang: None; X. He: None; S. van der Zade: None; M. Krekorian: None; P. Singh: None; E. Dik: None; G. Pruijn: None; T. Gordon: None; H. Koenen: None; M. Huijnen: None; R. Thurlings: None.

To cite this abstract in AMA style:

Papadimitriou T, Wang J, He X, van der Zade S, Krekorian M, Singh P, Dik E, Pruijn G, Gordon T, Koenen H, Huijnen M, Thurlings R. Rheumatoid Factor B Cell Clones Proliferate Predominantly as Atypical Memory B Cells in Reactive Cervical Lymph Node Follicles Compared to Extrafollicular Sites in Affected Salivary Glands of SjS Patients [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/rheumatoid-factor-b-cell-clones-proliferate-predominantly-as-atypical-memory-b-cells-in-reactive-cervical-lymph-node-follicles-compared-to-extrafollicular-sites-in-affected-salivary-glands-of-sjs-pati/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rheumatoid-factor-b-cell-clones-proliferate-predominantly-as-atypical-memory-b-cells-in-reactive-cervical-lymph-node-follicles-compared-to-extrafollicular-sites-in-affected-salivary-glands-of-sjs-pati/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology